Amgen (AMGN) EV to FCF (2009 - 2026)
Amgen (AMGN) posted EV to FCF of 52.1 for Q2 2026, down 56.73% on a QoQ basis from 120.42 in Q1 2026, and down 30.02% year-over-year from 74.45 in Q2 2025.
Analysis
Amgen (AMGN) EV to FCF (2009 - 2026) Analysis & Trends
Amgen has reported EV to FCF for 18 years, with the latest figure at 52.1 in Q2 2026.
- On a quarterly basis, EV to FCF fell 30.02% year-over-year to 52.1 in Q2 2026; TTM through Jun 2026 was 17.86, a 33.17% increase from a year earlier, with the FY2025 full-year figure at 20.65, up 67.69% from the prior year.
- EV to FCF was 52.1 for Q2 2026 at Amgen, down from 120.42 in the prior quarter.
- The five-year high for EV to FCF was 495.72 in Q4 2023, with the low at 22.02 in Q2 2023.
- Average EV to FCF over 5 years is 111.37, with a median of 66.76 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: EV to FCF surged 774.12% in 2023, then tumbled 94.13% in 2024.
- Over 5 years, EV to FCF stood at 56.71 in 2022, then soared by 774.12% to 495.72 in 2023, then sank by 94.13% to 29.08 in 2024, then soared by 498.33% to 174.01 in 2025, then plunged by 70.06% to 52.1 in 2026.
- The last three EV to FCF figures came in at 52.1 (Q2 2026), 120.42 (Q1 2026), and 174.01 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.10 |
| Mar 31, 2026 | 120.42 |
| Dec 31, 2025 | 174.01 |
| Sep 30, 2025 | 33.55 |
| Jun 30, 2025 | 74.45 |
| Mar 31, 2025 | 161.95 |
| Dec 31, 2024 | 29.08 |
| Sep 30, 2024 | 49.54 |
| Jun 30, 2024 | 71.39 |
| Mar 31, 2024 | 311.11 |
| Dec 31, 2023 | 495.72 |
| Sep 30, 2023 | 43.42 |
| Jun 30, 2023 | 22.02 |
| Mar 31, 2023 | 135.51 |
| Dec 31, 2022 | 56.71 |
| Sep 30, 2022 | 38.60 |
| Jun 30, 2022 | 73.02 |
| Mar 31, 2022 | 62.13 |
| Dec 31, 2021 | 46.63 |
| Sep 30, 2021 | 49.28 |